Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs propofol for cardiac protection in sepsis
ChiCTR2000040821Phase 4Completed
- Sponsor
- The Affiliated Hospital of Guangdong Medical University
- Start
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in sepsis and septic cardiomyopathy (SCM) comparing Dexmedetomidine group with Propofol group (2 arms). Primary endpoints: Cardiac troponin I (cTnI), Pro–B-type natriuretic peptide (proBNP) and 5 more. Started Dec 2017; status: completed.
02
Drugs
dexmedetomidinepropofol
03
Conditions
sepsisseptic cardiomyopathy (SCM)
Beyond the preview
Go deeper on ChiCTR2000040821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000040821.